Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEMAU: MMR Non-specific Effects in Children
NCT05758532Phase 4Recruiting
- Start
- Mar 2023
- Primary completion
- Apr 2026
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of M-M-R II in respiratory tract infection (RTI), atopic diseases. Started Mar 2023; status: recruiting.
02
Drugs
M-M-R II
03
Conditions
respiratory tract infection (RTI)atopic diseases
Beyond the preview
Go deeper on NCT05758532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05758532.